Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Zevra Therapeutics Prices $60M Public Offering Of 9,230,770 Common Shares At $6.50/Share

Author: Benzinga Newsdesk | August 09, 2024 01:12am

The offering is expected to close on August 12, 2024, subject to customary closing conditions.

Posted In: ZVRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist